Max Robotics — Global Service Robot Directory + US Certification

About

Pavana Anur is a researcher whose work sits at the critical intersection of population genomics, public health, and hereditary disease prevention. Her primary research focus is on the implementation and outcomes of large-scale genetic screening programs, particularly for actionable inherited conditions. Anur’s most notable contribution is her landmark 2023 study, "Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon," which has already garnered 13 citations. This work provides compelling evidence for the feasibility and impact of broad, unselected genomic screening in a real-world population, demonstrating that such programs can identify individuals at high risk for hereditary cancers and familial hypercholesterolemia who would otherwise be missed by traditional family-history-based approaches. By quantifying the prevalence of these actionable genetic variants in a general population, Anur’s research directly informs public health policy and clinical practice, moving beyond high-risk clinics to a preventive model. Her findings are a powerful testament to the potential of population-level genomics to reduce the burden of preventable disease, making her a key voice in the evolving conversation around equitable, proactive healthcare.